PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Tower expands pharmaceutical corridors with new Singapore site

Pharmaceutical thermal protection specialist Tower Cold Chain is opening new office space in Tampines, Singapore, to support the company’s growth in the Asia Pacific region.

Located just a 10-minute drive from Singapore Changi Airport, the facility will greatly expand Tower’s proximity and availability to customers, improving their access to its commercial and operational personnel.

The new Singapore site features private offices which are available for customer use, providing a space for meetings and consultations, streamlining Tower’s admin presence in the APAC.

The facility is now a base for six industry experts, who are on hand to provide support to Tower customers 24 hours, 365 days a year.

“The opening of the Singapore office is another important milestone in the continued global growth of Tower Cold Chain,” commented Niall Balfour, Tower’s CEO.

“To meet the growing demand for reliable temperature-controlled solutions to the APAC pharmaceutical, airline and 3PL markets, the Singapore site strengthens our service offerings and further underlines our commitment to provide quality-assured, dedicated cold chain services for temperature-sensitive pharmaceutical and biotech products.”

The new space will support Tower’s growing global network of strategically located hubs throughout APAC, EMEA, and The Americas regions – with a series of recent new hub openings including Incheon, Chicago and Milan. The company’s global standard operating system ensures ease of ordering for customers, matching their supply chain needs.

Tower’s extensive product offering also means it can supply containers at all pharmaceutical temperature configurations and standards to meet the different requirements of Euro, US, single and double pallets, as well as smaller sub-pallet consignments.

“The expansion of Tower’s network in Singapore reinforces our ability to deliver robust, reliable, reusable temperature-controlled containers to meet our customers’ needs at every corner of the globe,” said Robert Paterson, Tower’s Regional Commercial Manager of Asia Pacific. “The new Singapore office strengthens our commercial and

operational infrastructure to support the growing APAC pharmaceutical market and airline industries as the need for transparent and closely controlled global supply chain demands rise.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026